BIONIME (4737.TW) monthly revenue, September 2026
BIONIME reported revenue of NT$0.18bn for September 2026, up 20.0% from the previous month and up 20.9% from a year earlier. Year-to-date revenue was NT$1.31bn, down 7.4% year on year. It ranked 54 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.18 | 20.0 | 20.9 |